Sign In
Buy NVAX
$7.89
-0.0600 (-0.755%)
At Close: Aug 10, 2026
Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript
02:10pm, Thursday, 04'th Sep 2025
Novavax, Inc. (NASDAQ:NVAX ) Cantor Global Healthcare Conference 2025 September 4, 2025 10:20 AM EDT Company Participants John Jacobs - President, CEO & Director Ruxandra Draghia-Akli - Executive VP a
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
08:00am, Thursday, 04'th Sep 2025
GAITHERSBURG, Md. , Sept. 4, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced a milestone payment* from Takeda has been triggered by regulatory approval for Novavax's COVID-19 vacci
FDA Approves Updated COVID-19 Vaccines but With Restrictions
01:06pm, Thursday, 28'th Aug 2025
FDA clears updated COVID-19 vaccines from Pfizer, Moderna and Novavax but limits access to older adults and high-risk groups.
Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term
10:50am, Thursday, 28'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
03:07pm, Wednesday, 27'th Aug 2025
Nuvaxovid™ is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season GAITHERSBURG, Md. , Aug. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NV
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Wednesday, 27'th Aug 2025
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax Announces Convertible Debt Refinancing
07:43am, Thursday, 21'st Aug 2025
Refinancing extends maturity of most existing debt with improved terms $225 million of convertible notes due in 2031 issued, including a ~$175 million exchange for the retirement of existing convertib
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:01am, Wednesday, 13'th Aug 2025
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View
12:16pm, Thursday, 07'th Aug 2025
Novavax tops Q2 estimates and lifts 2025 sales forecast as Sanofi takes over global rollout of its COVID vaccine.
Novavax (NVAX) Profit Jumps on Milestone
05:13pm, Wednesday, 06'th Aug 2025
Novavax (NVAX) Profit Jumps on Milestone
Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript
03:56pm, Wednesday, 06'th Aug 2025
Novavax, Inc. (NASDAQ:NVAX ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants James Patrick Kelly - Executive VP, CFO & Treasurer John Charles Jacobs - President, CEO &
Novavax (NVAX) Q2 Earnings and Revenues Top Estimates
10:11am, Wednesday, 06'th Aug 2025
Novavax (NVAX) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to earnings of $0.99 per share a year ago.
Novavax beats quarterly revenue estimates on milestone payment
08:08am, Wednesday, 06'th Aug 2025
Novavax beat Wall Street expectations for second-quarter revenue on Wednesday, helped by a $175 million milestone payment related to U.S. approval of its COVID-19 vaccine in May.
Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights
08:00am, Wednesday, 06'th Aug 2025
Total revenue of $239 million in the second quarter of 2025 Received FDA BLA approval for Nuvaxovid™, the only recombinant protein-based, non-mRNA COVID-19 vaccine available in the U.S.; approval t
Novavax (NVAX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
06:45pm, Wednesday, 30'th Jul 2025
In the most recent trading session, Novavax (NVAX) closed at $6.85, indicating a -2.28% shift from the previous trading day.
